PMGC Holdings Inc. (ELAB) stock
ELABNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/3095% below fair value
$1.47−0.01 (-0.68%)
Close on Nov 18, 2026Market cap $1.31MP/E –Yield –
PMGC operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2025 | Sep 30, 2025 | -$2.20M | – |
| Q3 FY2024 | Sep 30, 2024 | -$625.62K | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.41M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.68M | – |
| Q3 FY2023 | Sep 30, 2023 | -$785.55K | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.05M | – |
| Q1 FY2023 | Mar 31, 2023 | -$846.39K | – |
See a number that looks wrong?